Is serum ferritin an additional cardiovascular risk factor for all postmenopausal women?

Annals of Nutrition and Metabolism

Volumn 48, Issue 6, 2004, Pages 381-389

  Masse, Priscilla G ^a   Dosy, Juliana ^a   Cole, D E C ^c   Evroski, J ^c   Allard, Jacques ^a   D'Astous, Michel ^b  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b Dumont Hospital   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Cardiovascular disease; Estrogen; Ferritin; Homocysteine; Lipoprotein levels; Menopause

Indexed keywords

ESTROGEN; FERRITIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY FAT; BODY WEIGHT; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; FEMALE; FERRITIN BLOOD LEVEL; HEART RATE; HUMAN; IRON INTAKE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NUTRITIONAL REQUIREMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HOMOCYSTEINE; HUMANS; IRON; LIPOPROTEINS, LDL; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; TRIGLYCERIDES;

EID: 16344374707     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082366     Document Type: Article

References (52)

1. Stampfer M, Colditz G, Willett W, Manson J, Rosner B, Speizer F: Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-762.
2. Lindquist O: Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: Results from a prospective population study of women in Goteborg, Sweden. Prev Med 1982;11:162-172.
3. Wakatsuki A, Sagara Y: Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol 1995;83:523-528.
4. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1981;i:1293-1294.
5. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppyanen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811.
6. Corti MC, Gaziano M, Hennekens CH: Iron status and risk of cardiovascular disease. Ann Epidemiol 1997;7:62-68.
7. Sempos CT, Looker AC, Gillum RF, Makuc DM: Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-1124.
8. Cattaneo M: Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999;81:165-176.
9. Harker LA, Harlan JM, Ross R: Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res 1983;53:731-739.
10. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:1049-1057.
11. Rees MM, Rodgers GM: Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337-359.
12. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G: Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The atherosclerosis risk in community study. Circulation 1993;87:1107-1113.
13. Malinow MR: Plasma homocysteine and arterial occlusive diseases: A mini-review. Clin Chem 1995;41:173-176.
14. Brattström LE, Hultberg BL, Hardebo JE: Folic acid-responsive postmenopausal homocysteinemia. Metabolism 1985;34:1073-1077.
15. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236.
16. Refsum H, Ueland P, Nygård O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
17. Giles, WH, Kittner SJ, Croft JB, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Price TR: Distribution and correlates of elevated total homocysteine: The Stroke Prevention in Young Women study. Ann Epidemiol 1999;9:307-313.
18. Roeters van Lennep JE, Westerveld der Wall HT, Erkelens DW, van der Wall EE: Risk factors for coronary heart disease: Implications of gender. Cardiovasc Res 2002;53:538-549.
19. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GHJ, Schellekens LA, Thomas CMG, Eskers TKAB: Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-805.
20. Hak AE, Polderman KH, Westendorp IC, Jacobs C, Hofman A, Witteman JCM, Stehouwer CDA: Increased plasma homocysteine after menopause. Atherosclerosis 2000;149:163-168.
21. Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B: Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1991;22:79-87.
22. Masse PG, Dosy J, Cole DEC, Evroski J, Mahuren JD, Coburn SP: Elevation of plasma homocysteine in natural menopause cannot be explained by lack of vitamin coenzyme availability: Relevance to the risk of cardiovascular disease. J Nutr Health Aging 2005;7: in press.
23. Bray GA, Gray DS: Anthropometric measurements in the obese; in Lohman TG, Roche AF, Martorell R (eds): Anthropometric Standardization Reference Manual. Champaign, Human Kinetics, 1988, pp 131-136.
24. Callaway CW, Chumlea WC, Bouchard C, Himes JH, Lohman TG, Martin AD, Mitchell CD, Mueller WH, Roche AF, Seefeldt VD: Circumferences; in Lohman TG, Roche AF, Martorell R (eds): Anthropometric Standardization Reference Manual. Champaign, Human Kinetics 1988, pp 39-54.
25. Santé Canada (Health Canada): Laboratoire de lutte contre les maladies. Division de la santé de Statistique Canada. «Les principales causes de décès au Canada», 1995.
26. Committee on Dietary Intakes: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, National Academy Press, 2002.
27. Food and Nutrition Board, Institute of Medicine: Dietary References Intakes (DRI). Washington, National Academy Press, 1999.
28. Evrovski J, Callaghan M, Cole DEC: Determination of homocysteine by HPLC with pulsed integrated amperometry. Clin Chem 1995;41:757-758.
29. Ueland PM, Refsum H, Malinow MR, Andersson A, Allen RH: Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993;39:1764-1779.
30. Posner BM, Cupples LA, Miller DR, Cobb JL, Lutz KJ, D'Agostino RB: Diet, menopause and serum cholesterol levels in women: The Framingham Study. Am Heart J 1993;125:483-489.
31. Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Frachart JC, Amouyvel P: Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995;118:123-133.
32. Ikenoue N, Wakatsuki A, Okatani Y: Small low-density lipoprotein particles in women with natural or surgically induced menopause. Gynecology 1999;93:566-570.
33. Peters HW, Westendorp IC, Hak AE, Grobbee DE, Stehouwer CD, Hofman A, Witteman JC: Menopausal status and risk factors for cardiovascular disease. J Intern Med 1999;246:521-528.
34. Davis CE, Pajak A, Rywik S, Williams DH, Broda G, Pazucha T, Ephross S: Natural menopause and cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. Ann Epidemiol 1994;4:445-448.
35. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204.
36. Wakatsuki A, Ikenoue N, Sagara Y: Estrogen-induced small low-density lipoprotein particles in postmenopausal women Obstet Gynecol 1998;91:234-240.
37. Demirovic J, Sprafka JM, Folsom AR, Laitnen D, Blackburn H: Menopause and serum cholesterol: Differences between blacks and whites. Am J Epidemiol 1992;136:155-164.
38. Jensen J, Nilas L, Christiansen C: Influence of menopause on serum lipids and lipoproteins. Maturitas 1990;12:321-331.
39. Brown SA, Hutchinson R, Morrisett J, Boerwinckle E, Davis CE, Gotto AM, Patsch W: Plasma lipid, lipoprotein cholesterol and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1139-1158.
40. Naimark BJ, Ready E, Sawatzky JAV, Boreskie S, Ducas J, Drinkwater DT, Oosterveen S: Serum ferritin and heart disease: The effect of moderate exercise on stored iron levels in postmenopausal women. Can J Cardiol 1996;12:1253-1257.
41. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM: Low-density lipoprotein subclass patterns and the risk of myocardial infarction. J Am Med Assoc 1988; 260:1917-1921.
42. Nigon F, Lesnik P, Rouis M, Chapman MJ: Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991;32:1741-1753.
43. Tribble DL, Holl LG, Wood PD, Krauss RM: Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992;93:189-199.
44. Halliwell B: Free radicals, antioxidants and human disease: Curiosity, cause and consequence. Lancet 1994;344:721-724.
45. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
46. 6-deficient tarsometatarsal chick cartilage. Scanning Microsc 1990;4:667-674.
47. Majors A, Ehrhart LA, Pezacka EHB: Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-2081.
48. Berge LN, Bønaa KH, Nordøy A: Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arterioscler Thromb 1994;14:857-861.
49. Ramakrishnan U, Kuklina E, Stein AD: Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am J Clin Nutr 2002;76:1256-1260.
50. Veerkamp MJ, de Graaf J, den Heijer M, Blom HJ, Stalenhoef AFH: Plasma homocysteine in subjects with familial combined hyperlipidemia. Atherosclerosis 2003;166:111-117.
51. Tonstad S: Correlates of plasma total homocysteine in patients with hyperlipidaemia. Eur J Clin Invest 1997;27:1025-1029.
52. Frauscher G, Kamaukhova E, Muehl A, Hoeger H, Lubec B: Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid. Additional mechanisms in homocysteine-induced endothelial damage. Life Sci 1995;57:813-817.